Immix Biopharma, Inc. Business Finance Contracts & Agreements
13 Contracts & Agreements
- Note Agreements (1 contract)
- Purchase Agreements (1)
- Share Agreements (1)
- Stock Agreements (5)
- Underwriting Agreements (2)
- Warrant Agreements (3)
- Immix Biopharma, Inc., Form of Stock Option Grant Notice and Option Agreement (Effective August 2023 Yekaterina Chudnovsky Grant (20,000)) (Filed With SEC on November 13, 2023)
- Immix Biopharma, Inc., Form of Stock Option Grant Notice and Option Agreement (Effective August 2023 Yekaterina Chudnovsky Grant (16,670)) (Filed With SEC on November 13, 2023)
- Immix Biopharma, Inc., Form of Stock Option Grant Notice and Option Agreement (Directors August 2023) (Filed With SEC on November 13, 2023)
- Immix Biopharma, Inc., Form of Stock Option Grant Notice and Option Agreement (Executive Officers August 2023) (Filed With SEC on November 13, 2023)
- Form of Securities Purchase Agreement dated August 21, 2023 (Filed With SEC on August 22, 2023)
- Form of Pre-Funded Warrant to Purchase Common Stock (Filed With SEC on August 22, 2023)
- Senior Unsecured Promissory Note issued by Nexcella, Inc. to Immix Biopharma, Inc. on December 21, 2022 (Filed With SEC on March 27, 2023)
- Form of Share Purchase Agreement (Filed With SEC on January 18, 2023)
- Form of Representatives Warrant (Filed With SEC on May 27, 2022)
- Form of Underwriting Agreement (Filed With SEC on May 27, 2022)
- Form of Representatives Warrant (Filed With SEC on October 28, 2021)
- Form of Underwriting Agreement (Filed With SEC on October 28, 2021)
- Specimen Stock Certificate evidencing the shares of common stock (Filed With SEC on October 6, 2021)